Showing papers in "Journal of the Neurological Sciences in 2020"

TL;DR: It is highly likely that some of these patients, particularly those who suffer from a severe illness, have CNS involvement and neurological manifestations in patients with COVID-19, and the role played by this virus in causing neurological manifestations is clarified.

TL;DR: A comprehensive review of the neurological disorders reported during the current COVID-19 pandemic demonstrates that infection with SARS-CoV-2 affects the central nervous system, the peripheral nervous system (PNS) and the muscle.

TL;DR: The most common neurological complaints in COVID-19 were anosmia, ageusia, and headache, but more serious complications, such as stroke, impairment of consciousness, seizures, and encephalopathy, have also been reported.

TL;DR: A retrospective cohort study of patients admitted to a major healthcare system in New York City between March 1, 2020 and April 13, 2020 demonstrates acute stroke is the most common neuroimaging finding among hospitalized COVID-19 patients.

TL;DR: Despite similar baseline comorbidities and demographics, the COVID-19 patients who developed neurologic symptoms later in hospitalization had more severe disease courses.

TL;DR: In all 30 cases, RT-PCR for SARS-CoV-2 from CSF was negative and CSF analysis findings, including WBC, were normal in most patients with COVID-19.

TL;DR: Four cases demonstrate the occurrence of posterior reversible encephalopathy syndrome (PRES) in critically-ill patients with COVID-19, and PRES should be considered in the differential for acute neurological deficits and seizures in this setting.

TL;DR: How the recent pandemic has created a paradigm shift in caring for patients with chronic neurological disorders and how academic institutions have responded to the present need is reviewed and may have initiated a more permanent transition to virtual technology incorporated medical care.

TL;DR: Presence of encephalopathy is potentially a complication of severe SARS-CoV-2 infection and should be considered in COVID-19 patients with altered mentation, say doctors.

TL;DR: The first patient with COVID-19 developing an isolated SCC lesion on brain MRI is demonstrated, suggestive of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS), which can be considered as a differential diagnosis for neurological symptoms of CO VID-19.

TL;DR: Hospitalized Covid-19 patients with anosmia had a lower adjusted mortality rate and less severe course of the disease, which could be related to a distinct clinical presentation and a different inflammatory response.

TL;DR: Myasthenic crises is a potentially severe complication of COVID-19 and IVIg treatment may cause thrombosis in susceptible patients.

TL;DR: The adopted strategies for stroke management during the COVID-19 emergency have suggested being effective, while suffering a reduced and delayed reporting of symptoms.

TL;DR: The use of PAPR together with the N95 mask for healthcare-workers doing longer duties in the hospital wards was more comfortable as compared to N95 respirator-mask alone, and these effects are mitigated by the use of additional PPE.

TL;DR: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.

TL;DR: MS patients with more severe COVID-19 courses tended to be older, were more likely to suffer from progressive phenotype, and had a higher degree of disability, however, disease-modifying therapy use was not different among courses.

TL;DR: Alterations in brain networks related to reward processing, executive functioning, salience attribution, and habit formation and in neurochemical pathways that may include dopamine, serotonin, opioids, and other neurotransmitters may represent neurobiological factors involved in the development and maintenance of addictive behaviors.

TL;DR: Health policymakers should clarify a targeted model of disease surveillance in order to reduce the dual burden of dementia and COVID-19.

TL;DR: It is suggested that compared to non-SARS-CoV-2 infected patients, CVST occurs in older patients, with lower rates of known CVST risk factors and might lead to a poorer outcome in the SARS- CoV- 2 infected group.

TL;DR: COVID-19 neurology has a wide spectrum of dysimmune-thrombotic disorders and is widely perceived that the pandemic did not unduly affect Singapore healthcare system.

TL;DR: Twenty-one studies that were almost exclusively from the English literature published between 1990 and 2020 were identified via PubMed using relevant search terms and included patient populations from the United States, Canada, Japan, Egypt, and several countries in South America and Europe.

TL;DR: A patient with acute disseminated encephalitis and COVID-19 died of status epilepticus and brain MRI of the patient indicated diffuse confluent white matter hyperintensities.

TL;DR: Physicians will need to continue to balance the real potential of these compounds with their limitations and adverse effects as the legal status and clinical database of these medications continue to evolve.

TL;DR: SLLs are a unique feature of various MIDs in particular MELAS and show spontaneous reversibility suggesting that neuronal/glial damage does not reach the threshold of irreversible cell death.

TL;DR: In this paper, the authors highlight contemporary human studies on the use of select psychedelic drugs, such as psilocybin, LSD, MDMA and ayahuasca, in the treatment of various psychiatric illnesses, including but not limited to treatment-resistant depression, post-traumatic stress disorder, end-of-life anxiety, and substance use disorders.